|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
1994-8-25
|
|
pubmed:abstractText |
A randomized prospective study was performed to compare the efficacy and toxicity of high-dose intravenous bolus interleukin-2 (IL-2) and a lower-dose intravenous bolus regimen for the treatment of metastatic renal cell carcinoma (RCC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
1572-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8040669-Adult,
pubmed-meshheading:8040669-Carcinoma, Renal Cell,
pubmed-meshheading:8040669-Drug Administration Schedule,
pubmed-meshheading:8040669-Female,
pubmed-meshheading:8040669-Humans,
pubmed-meshheading:8040669-Infusions, Intravenous,
pubmed-meshheading:8040669-Injections, Intravenous,
pubmed-meshheading:8040669-Interleukin-2,
pubmed-meshheading:8040669-Kidney Neoplasms,
pubmed-meshheading:8040669-Male,
pubmed-meshheading:8040669-Middle Aged,
pubmed-meshheading:8040669-Prospective Studies
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Randomized comparison of high-dose and low-dose intravenous interleukin-2 for the therapy of metastatic renal cell carcinoma: an interim report.
|
|
pubmed:affiliation |
Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
